Part,  Chapter, Paragraph

1   II,     5. 15.Acr|      Organization of Rare Disorders~OD~Orphan Drugs~RD~Rare Diseases~ ~
2   II,     5. 15.  3|         data concerns Orphan Drugs (OD), drugs developed for a
3   II,     5. 15.  3|          the price of orphan drugs (OD). The study, conducted by
4   II,     5. 15.  3|           discuss the impact of the OD regulation and the economic
5   II,     5. 15.  3|            France. Three times more OD are expected to reach the
6   II,     5. 15.  4| developments in the field of RD and OD; empower patients with RD